share_log
Reuters ·  Apr 29 08:01
NKGen Biotech Inc: Expects to Initiate a Phase 1 Clinical Trial in Pd in 2H 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment